Victoria Nosal

Victoria Nosal serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and diagnostic capabilities. She manages complex contracting actions focused on laboratory instrumentation, infectious disease detection systems, and ambulatory health services infrastructure, ensuring timely delivery of mission-critical resources for disease surveillance and outbreak response. Her work directly enables CDC’s scientific and operational readiness by aligning procurement strategy with public health priorities, particularly in high-stakes, time-sensitive environments. Nosal maintains established relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, Cepheid, and New York City Health & Hospitals Corp. These partnerships reflect a preference for proven, high-capacity vendors with expertise in clinical diagnostics, analytical instrumentation, and large-scale public health service delivery. Her contracting approach emphasizes performance reliability, regulatory compliance, and technical scalability, often involving long-term service agreements and complex delivery order structures under multiple-award contracts. Nosal’s procurement portfolio reflects a strong orientation toward open competition, with 100% of awards issued under no set-aside categories. This indicates a deliberate focus on selecting the most technically qualified and capable providers regardless of socioeconomic status, prioritizing mission effectiveness over targeted socioeconomic preferences. While small business participation is not formally prioritized in her award patterns, her contracting actions remain fully compliant with all federal acquisition regulations. Her primary procurement focus lies in NAICS 621999 (miscellaneous ambulatory health services) and 334290 (other communications equipment manufacturing), with a significant secondary emphasis on 334516 (analytical laboratory instrument manufacturing). She routinely acquires next-generation diagnostic platforms, real-time data transmission systems, and point-of-care testing technologies that support CDC’s core functions in infectious disease monitoring and laboratory network modernization.